ONCOLOGY
September 17, 2019
Abbott RealTime IDH1
The Abbott RealTime IDH1 assay employs PCR technology with homogeneous fluorescence detection to identify IDH1 alterations in patients with acute myeloid leukemia.September 12, 2019
Trial Targets Options for Urothelial Carcinoma
August 22, 2019
Metabolic Changes May Predict Anthracycline Cardiotoxicity
August 22, 2019
Ice Chips Prevent Hyperalgesia With Oxaliplatin
August 22, 2019
Enzalutamide and ADT Reduce Prostate Cancer Progression Risk
August 19, 2019
Basal Cell Carcinoma: A Pharmacist’s Guide
August 16, 2019
PSA Test
June 18, 2019
Mouthwash BLM
Copyright © 2000 - 2019 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.